BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uehara T, Kanazawa T, Mizukami H, Uchibori R, Tsukahara T, Urabe M, Kume A, Misawa K, Carey TE, Suzuki M, Ichimura K, Ozawa K. Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells. Cancer Sci 2014;105:72-80. [PMID: 24168112 DOI: 10.1111/cas.12315] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Sánchez ML, Coveñas R. The Galaninergic System: A Target for Cancer Treatment. Cancers 2022;14:3755. [DOI: 10.3390/cancers14153755] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kiezun J, Godlewski J, Krazinski BE, Kozielec Z, Kmiec Z. Galanin Receptors (GalR1, GalR2, and GalR3) Expression in Colorectal Cancer Tissue and Correlations to the Overall Survival and Poor Prognosis of CRC Patients. Int J Mol Sci 2022;23:3735. [PMID: 35409094 DOI: 10.3390/ijms23073735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Shi H, Fang Y, Huang L, Gao L, Lenahan C, Okada T, Travis ZD, Xie S, Tang H, Lu Q, Liu R, Tang J, Cheng Y, Zhang JH. Activation of Galanin Receptor 1 with M617 Attenuates Neuronal Apoptosis via ERK/GSK-3β/TIP60 Pathway After Subarachnoid Hemorrhage in Rats. Neurotherapeutics 2021. [PMID: 34086200 DOI: 10.1007/s13311-021-01066-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wu VH, Gutkind JS. GPCRs in head and neck squamous cell carcinoma. Improving the Therapeutic Ratio in Head and Neck Cancer 2020. [DOI: 10.1016/b978-0-12-817868-3.00015-9] [Reference Citation Analysis]
5 Kanazawa T, Misawa K, Shinmura K, Misawa Y, Kusaka G, Maruta M, Sasaki T, Watanabe Y, Carey TE. Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas. Expert Rev Mol Diagn 2019;19:137-48. [PMID: 30640567 DOI: 10.1080/14737159.2019.1567334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
6 Zhang L, Fang P, Chai C, Shao L, Mao H, Qiao D, Kong G, Dong X, Shi M, Zhang Z, Bo P. Galanin expression is down-regulated in patients with gastric cancer. J Int Med Res 2019;47:1241-9. [PMID: 30616468 DOI: 10.1177/0300060518819382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Yoon D, Bae K, Lee MK, Kim JH, Yoon KA. Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells. PLoS One 2018;13:e0193275. [PMID: 29462183 DOI: 10.1371/journal.pone.0193275] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Song J, Kim OY. Galanin's implications for post-stroke improvement. Anat Cell Biol 2016;49:223-30. [PMID: 28127496 DOI: 10.5115/acb.2016.49.4.223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Kanazawa T, Misawa K, Misawa Y, Uehara T, Fukushima H, Kusaka G, Maruta M, Carey TE. G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer? Toxins (Basel) 2015;7:2959-84. [PMID: 26251921 DOI: 10.3390/toxins7082959] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
10 Lang R, Gundlach AL, Holmes FE, Hobson SA, Wynick D, Hökfelt T, Kofler B. Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity. Pharmacol Rev 2015;67:118-75. [PMID: 25428932 DOI: 10.1124/pr.112.006536] [Cited by in Crossref: 215] [Cited by in F6Publishing: 224] [Article Influence: 30.7] [Reference Citation Analysis]
11 Banerjee R, Van Tubergen EA, Scanlon CS, Vander Broek R, Lints JP, Liu M, Russo N, Inglehart RC, Wang Y, Polverini PJ, Kirkwood KL, D'Silva NJ. The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer. Mol Cancer Ther 2014;13:1323-33. [PMID: 24568968 DOI: 10.1158/1535-7163.MCT-13-0904] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]